Raltegravir is an integrase transfer inhibitor antiretroviral agent used in the treatment of HIV-1 infection in combination with other antiretroviral agents.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| HIV Human Immunodeficiency Virus | 66 |
|
|
6 | |||
| Other | 1 |
|
1 | ||||
| Improve immune function | 1 |
|
1 |
See all 86 patients currently taking Raltegravir
Mouse over the table for more information
Top 10 dosages based on patients currently taking Raltegravir. See all 12 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
1 | 50% |
|
|
Side effects too severe
|
1 | 50% |
|
|
Not indicated
|
1 | 50% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 17, 2010.